Yew Bio Pharm Balance Sheet - Quarterly (OTCMKTS:YEWB)

Add to My Stocks
$0.24 $0 (0%) YEWB stock closing price Jan 20, 2017 (Closing)

The fundamental analysis of this company requires a thorough look at Yew Bio Pharm balance sheet. Balance sheet items like cash at hand, total assets and liabilities helps one analyze a company and summarize the financial performance of the company like we have in our Yew Bio Pharm stock analysis. Quarterly results announcements include the release of all three financial statements, of which the balance sheet is one. Yew Bio Pharm operating cash flow was $0.36M while Yew Bio Pharm revenue stood at $14.67M. View Yew Bio Pharm quarterly results to get the balance sheet details for the latest & last 40 quarters data..

show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec. 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2
Marketable Securities----------
Raw Materials0.62M0.68M4.28M3.33M2.39M2.57M1.91M1.44M1.64M0.78M
Work In Progress----------
Finished Goods11.94M7.97M5.48M1.33M5.39M0.93M0.78M-0.08M0.08M
Notes Receivable----------
Other Current Assets0.13M0.18M1.27M0.17M0.64M2.13M0.03M0.02M0.04M0.04M
Yew Bio Pharm Total Current Assets
Property Plant & Equipment---1.74M---1.89M--
Accumulated Depreciation---1.04M---1.03M--
Yew Bio Pharm Net Property Plant & Equipment
Investment & Advances----------
Other Non-Current Assets----------
Deferred Charges----------
Deposits & Other Assets14.41M14.5M11.51M12.33M11.39M11.08M10.86M10.66M10.55M10.01M
Yew Bio Pharm Total Assets
Notes Payable0.6M---------
Accounts Payable1.94M0.11M0.11M0.05M2.22M0.42M1.21M-0.01M0.04M
Current Portion Long-Term Debt3.82M3.76M3.83M3.84M2.33M2.33M0.04M0.04M0.29M1.04M
Current Portion Capital Leases----------
Accrued Expenses0.49M0.28M0.1M0.12M0.17M0.26M0.13M0.08M0.12M0.13M
Income Taxes Payable0.01M0.01M0.02M0.01M0.04M0.01M0.04M0.01M-0.01M
Other Current Liabilities----0.16M0.06M----
Yew Bio Pharm Total Current Liabilities
Deferred Taxes/Income----------
Convertible Debt----------
Long-Term Debt----------
Non-Current Capital Leases----------
Other Long-Term Liabilities----------
Yew Bio Pharm Total Liabilities
Minority Interest----------
Preferred Stock----------
Common Stock Net0.05M0.05M0.05M0.05M0.05M0.05M0.05M0.05M0.05M0.05M
Capital Surplus9.86M9.78M9.7M9.62M9.36M9.1M8.86M8.55M8.38M8.05M
Retained Earnings28.1M27.15M25.99M25.06M23.84M23.04M21.26M20.44M19.92M19.16M
Treasury Stock----------
Other Liabilities3.72M3.8M4.82M4.42M5.02M6.59M6.23M5.84M5.75M5.61M
Yew Bio Pharm Shareholders Equity
Yew Bio Pharm Total Liabilities & Shareholders Equity
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters
Get Balance sheet for another ticker

Most investors just check the Yew Bio Pharm stock price, and Yew Bio Pharm historical stock prices before investing. While share price is an important factor, one should also look at financials and valuation metrics like the Yew Bio Pharm PE ratio chart. Below is a brief explanation of common balance sheet terms:
  • Assets: YEWB total assets, which was at $48.62M for 2016-Q3 is a balance sheet item representing value of what Yew Bio Pharm owns. Assets are brought to aid a firms operations, or to increase its economic value. It must be noted that tech stocks may not have a lot of assets, as the value for these companies is often derived from future earning potential.
  • Liabilities or obligations comprise of current liabilities that include short term loans, amounts payable to suppliers, or any other outstanding payments including long term liabilities that take into account long term loans for funding large projects. The total liabilities for Yew Bio Pharm is $6.86M. Shareholders' equity comes under liabilities as it is money the company owes the holders of YEWB stock.

Yew Bio Pharm Balance Sheet - Key Ratios

Current ratio
Debt to Equity ratio
Asset Turnover
receivables turnover
PB ratio (
price to book ratio